The proposed acquisition of Roboticom would expand HCTI into industrial robotics and precision automation; Roboticom management's five-year forward-looking projections target $153.5 million in revenue and $64 million in adjusted operating contribution by fiscal year 2029/30; the projections were provided by Roboticom management, are unaudited and unverified by HCTI, subject to significant uncertainty, and actual results may differ materially.

拟议收购Roboticom将使HCTI拓展至工业机器人和精密自动化领域；Roboticom管理层提供的五年前瞻性预测目标为，到2029/30财年实现营业收入1.535亿美元、调整后经营贡献6,400万美元；该等预测由Roboticom管理层提供，未经HCTI审计或核实，存在重大不确定性，实际结果可能与预测存在重大差异。

PLEASANTON, Calif.

加利福尼亚州普莱森顿

,

，

Sept. 23, 2026

2026年9月23日

/PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq:

/美通社/ -- Healthcare Triangle, Inc.（纳斯达克股票代码：

HCTI

HCTI

) ('HCTI' or the 'Company') today announced it has signed a non-binding Letter of Intent ('LOI') with Crestpoint Capital LLC ('Seller') outlining a proposed transaction in which HCTI would acquire certain intellectual property, trademarks and business assets associated with Roboticom (roboticom.it), a Pisa, Italy-based provider of industrial robotic automation systems for precision surface treatment, marketed under the SandRob™, ORTIS™ and ScultoRob™ product lines and serving aerospace, marine, composites, orthotics and prosthetics, and industrial-tooling customers..

HCTI（以下简称“HCTI”或“公司”）今日宣布，已与Crestpoint Capital LLC（以下简称“卖方”）签署一份非约束性意向书（“LOI”），概述一项拟议交易，根据该交易，HCTI将收购与Roboticom（roboticom.it）相关的某些知识产权、商标和业务资产。Roboticom是一家位于意大利比萨的公司，提供用于精密表面处理的工业机器人自动化系统，其产品以SandRob™、ORTIS™和ScultoRob™系列品牌进行市场推广，客户涵盖航空航天、海洋工程、复合材料、矫形器与假肢以及工业工具制造等领域。

HCTI believes that, if consummated, the proposed acquisition could potentially extend the Company's technology platform beyond healthcare into industrial automation and advanced manufacturing — sectors the Company believes are experiencing significant growth driven in part by AI adoption — while creating an opportunity to combine HCTI's existing artificial intelligence, cloud and data capabilities with Roboticom's established industrial robotics platform..

HCTI认为，如果拟议的收购得以完成，可能会将公司的技术平台从医疗保健领域扩展到工业自动化和先进制造领域——公司认为这些行业正经历显著增长，部分原因是人工智能的应用——同时创造了一个机会，将HCTI现有的人工智能、云计算和数据能力与Roboticom成熟的工业机器人平台相结合。

Roboticom's technology is marketed through its SandRob™, ORTIS™ and ScultoRob™ product lines and serves applications across aerospace, marine, composites, orthotics and prosthetics, automotive, advanced manufacturing and industrial tooling.

Roboticom 的技术通过其 SandRob™、ORTIS™ 和 ScultoRob™ 产品线进行市场推广，服务于航空航天、海洋工程、复合材料、矫形器与假肢、汽车、先进制造以及工业工装等领域的应用。

Based on unaudited financial information provided by Roboticom's current ownership group, the business generated approximately $14.1 million in revenue and $6.9 million in gross margin and was EBITDA-positive for fiscal year 2025.

根据Roboticom现有所有权集团提供的未经审计的财务信息，该公司在2025财年实现了约1,410万美元的收入和690万美元的毛利润，并实现了正向的息税折旧摊销前利润（EBITDA）。

Roboticom management's five-year Growth and Operating Plan, prepared solely by Roboticom management, targets the business to reach approximately $153.5 million in revenue and $64 million in adjusted operating contribution by fiscal year 2029/30. 'Adjusted operating contribution' is a non-GAAP financial measure that has not been reconciled to the most directly comparable GAAP measure and may not be comparable to similarly titled measures used by other companies.

Roboticom 管理层编制的五年增长与运营计划（由 Roboticom 管理层独立制定）目标是在 2029/30 财年实现约 1.535 亿美元的收入和 6,400 万美元的经调整经营贡献。“经调整经营贡献”是一项非 GAAP 财务指标，未与最直接可比的 GAAP 指标进行调节，且可能无法与其他公司使用的类似名称指标相媲美。

HCTI is not adopting or endorsing these projections, and investors should not place undue reliance on them. The projections are unaudited, have not been independently verified by HCTI, and remain subject to significant assumptions, uncertainties and confirmation through due diligence, actual results may differ materially..

HCTI 并未采纳或认可这些预测，投资者不应过度依赖它们。这些预测未经审计，也未由 HCTI 独立核实，仍然受制于重大假设、不确定性以及通过尽职调查进行的确认，实际结果可能会有重大差异。

Proposed Transaction Structure

拟议交易结构

Under the terms outlined in the LOI, HCTI would acquire 100% of the customer contracts, identified intellectual property, trademarks and business assets for total consideration of up to $30 million in cash and equity paid over time.

根据意向书（LOI）中概述的条款，HCTI 将收购100%的客户合同、已识别的知识产权、商标和业务资产，总对价高达3,000万美元，以现金和股权形式分期支付。

Management Comment

管理层评论

'I believe this could represent a significant opportunity for HCTI. I am pleased to explore entering the robotics space and the prospect of combining our AI technology with this business to enhance its competitive positioning.'

“我相信这将为HCTI带来一个重要的机遇。我很高兴能够探索进入机器人领域，并展望将我们的人工智能技术与该业务相结合，以提升其竞争地位。”

— David Ayanoglou, Chief Financial Officer, Healthcare Triangle, Inc.

— David Ayanoglou，Healthcare Triangle, Inc. 首席财务官

About Roboticom

关于 Roboticom

According to publicly available information, Roboticom is a brand of Fabrica Machinale Srl, an Epica International company, based in Navacchio di Cascina (Pisa), Italy, with a commercial presence in Landrum, South Carolina. Its robotic automation systems — including the SandRob™, ORTIS™ and ScultoRob™ product lines and ARPP® software — serve aerospace, automotive, solid-surface, orthopedics, sanitary ware, art and design, woodworking and foundry customers.

根据公开信息，Roboticom 是 Epica International 旗下公司 Fabrica Machinale Srl 的一个品牌，总部位于意大利比萨省卡希纳的纳瓦基奥，并在南卡罗来纳州兰德勒姆设有商业机构。其机器人自动化系统——包括 SandRob™、ORTIS™ 和 ScultoRob™ 产品线以及 ARPP® 软件——服务于航空航天、汽车、实体面材、骨科、卫浴、艺术与设计、木工和铸造行业的客户。

HCTI's due diligence will include confirmation of the Seller's title to the assets described in the LOI. Descriptions of Roboticom and its business in this release are based solely on information provided by and representations made by the Seller, have not been independently verified by HCTI, and are included for informational purposes only..

HCTI的尽职调查将包括确认卖方对意向书（LOI）中所述资产的所有权。本新闻稿中对Roboticom及其业务的描述仅基于卖方提供的信息和作出的陈述，未经HCTI独立核实，且仅供信息参考之用。

About Healthcare Triangle, Inc.

关于 Healthcare Triangle, Inc.

Healthcare Triangle, Inc. (Nasdaq:

Healthcare Triangle, Inc.（纳斯达克：

HCTI

HCTI

), based in Pleasanton, California, reinforces healthcare progress through breakthrough technology and extensive industry knowledge and expertise. The Company supports healthcare organizations — including hospitals and health systems, payers, and pharma/life sciences organizations — in their effort to improve health outcomes through better utilization of the data and information technologies they rely on.

该公司总部位于加利福尼亚州普莱森顿，凭借突破性的技术以及深厚的行业知识与专业知识，推动医疗保健领域的进步。公司致力于支持各类医疗保健机构——包括医院和医疗系统、支付方以及制药与生命科学组织——通过更有效地利用其所依赖的数据和信息技术，改善健康 outcomes。

Healthcare Triangle's Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™, has achieved HITRUST Risk-based, 2-year (r2) Certified status, demonstrating to clients the highest standards for data protection and information security..

Healthcare Triangle 的云与数据平台（CaDP，以 CloudEz™ 和 DataEz™ 品牌进行市场推广）已获得 HITRUST 基于风险的两年期（r2）认证状态，向客户展示了其在数据保护和信息安全方面的最高标准。

Forward-Looking Statements and Safe Harbor Notice

前瞻性陈述与安全港声明

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 concerning the proposed acquisition of intellectual property, trademarks and business assets associated with Roboticom, including statements regarding the anticipated terms, timing, financing and completion of the proposed transaction, Roboticom's historical and projected financial performance, the potential future spin-off or public listing referenced in the LOI, and the anticipated strategic benefits to HCTI.

本新闻稿包含经修订的1995年《私人证券诉讼改革法》所界定的前瞻性陈述，涉及拟议收购与Roboticom相关的知识产权、商标及业务资产，包括有关拟议交易的预期条款、时间安排、融资及完成情况的陈述，Roboticom的历史及预测财务表现，意向书（LOI）中提及的潜在未来分拆或公开上市，以及对HCTI的预期战略利益。

Such forward-looking statements include words such as 'proposed,' 'intend,' 'anticipate,' 'target,' 'believe' and similar expressions. The fiscal year 2025 financial information was provided by Roboticom's current ownership group, and the fiscal year 2029/30 financial projections were prepared solely by Roboticom management; the projections are not adopted or endorsed by HCTI.

此类前瞻性陈述包括“拟议”、“打算”、“预期”、“目标”、“相信”等词语及类似表述。2025财年的财务信息由Roboticom当前的所有权集团提供，而2029/30财年的财务预测仅由Roboticom管理层编制；HCTI并未采纳或认可这些预测。

The financial information is unaudited, and the financial information and projections have not been independently verified by HCTI; they are subject to significant assumptions, risks and uncertainties, and investors should not place undue reliance on the projections. There is no assurance that Roboticom will achieve these historical results on a verified basis or any projected future results, and actual results may differ materially.

该财务信息未经审计，且HCTI未对该财务信息及预测进行独立验证；这些信息受重大假设、风险和不确定性的影响，投资者不应过度依赖这些预测。无法保证Roboticom能够在经核实的基础上实现这些历史业绩或任何预测的未来业绩，实际结果可能存在重大差异。

The LOI is non-binding, and the proposed transaction is subject to significant risks, uncertainties and conditions, including completion of satisfactory due diligence (including confirmation of clear title to the assets to be acquired), completion of an audit of the target's financial statements, HCTI's ability to secure financing, receipt of required approvals, integration risks, compliance with foreign regulatory requirements, and .

本意向书不具有法律约束力，拟议交易存在重大风险、不确定性和条件，包括完成令人满意的尽职调查（包括确认拟收购资产权属清晰）、完成对目标公司财务报表的审计、HCTI 获得融资的能力、取得所需批准、整合风险、遵守外国监管要求等。

www.sec.gov

www.sec.gov

. All forward-looking statements in this press release are qualified by these cautionary statements, and HCTI undertakes no obligation to update any forward-looking statement except as required by law.

本新闻稿中的所有前瞻性陈述均受上述警示性陈述的限定，除非法律另有要求，HCTI 不承担更新任何前瞻性陈述的义务。

Investor Contact

投资者联系

Healthcare Triangle, Inc.

医疗三角公司

1-800-617-9550

1-800-617-9550

[email protected]

[email protected]

SOURCE Healthcare Triangle, Inc.

来源：Healthcare Triangle, Inc.

21

二十一

%

百分比

more press release views with

更多新闻稿浏览量，通过

Request a Demo

申请演示